Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Adaptive Phage Therapeutics, Inc. See All Filings	D	2023-06-09 14:07:23 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001979814-23-000002 Exclusions or Exemptions 506b Accepted Date 2023-06-09 14:07:23 UTC Type of Offering D Industry Biotechnology Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
Adaptive Phage Therapeutics, Inc. See All Filings	D	2021-05-20 13:29:13 UTC
Amount To Be Raised $53,262,037 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001701259-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-05-20 13:29:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
Adaptive Phage Therapeutics, Inc. See All Filings	D/A	2020-08-27 12:32:31 UTC
Amount To Be Raised $3,650,000 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001701259-20-000003 Exclusions or Exemptions 506c Accepted Date 2020-08-27 12:32:31 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings	D	2020-08-24 10:02:42 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001701259-20-000002 Exclusions or Exemptions 506c Accepted Date 2020-08-24 10:02:42 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings	D	2020-06-19 20:57:07 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001701259-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-06-19 20:57:07 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings	D/A	2019-11-27 12:38:47 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001701259-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-11-27 12:38:47 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings	D	2018-06-04 18:26:28 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001701259-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-06-04 18:26:28 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt
Adaptive Phage Therapeutics, Inc. See All Filings	D	2017-04-13 17:42:13 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001701259 Filed Document 0001701259-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-04-13 17:42:13 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity